Panitumumab-based Maintenance in Patients With RAS Wild-type, Metastatic Colorectal Cancer (Valentino)

NCT02476045 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

224

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: 5-fluorouracil,leucovorin,panitumumab
DRUG: panitumumab
DRUG: Oxaliplatin, 5-fluorouracil,leucovorin,panitumumab

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano